KABACHNYJ, V. I.;CHERNYX, V. P.;KABACHNYJ, G. I.;SOPELNIK, E. M., XIM.-FARMATS. ZH., 1985, 19, N 1, 43-46
作者:KABACHNYJ, V. I.、CHERNYX, V. P.、KABACHNYJ, G. I.、SOPELNIK, E. M.
DOI:——
日期:——
INHIBITORS OF HEAT SHOCK FACTORS AND USES THEREOF
申请人:HSF Pharmaceuticals
公开号:EP3512602A2
公开(公告)日:2019-07-24
Inhibitors of heat shock factors and uses thereof
申请人:Vilaboa Nuria
公开号:US20210221778A1
公开(公告)日:2021-07-22
The present disclosure relates to a class of mammalian heat shock factor (HSF) inhibitors, to pharmaceutical compositions comprising these inhibitors as well as to methods for using the inhibitors. The inhibitors inhibit stress-induced expression from heat shock gene promoters. Furthermore, the inhibitors are cytotoxic to a variety of human cancer cells types.
[EN] INHIBITORS OF HEAT SHOCK FACTORS AND USES THEREOF<br/>[FR] INHIBITEURS DU FACTEUR DE CHOC THERMIQUE ET UTILISATIONS DE CEUX-CI
申请人:HSF PHARMACEUTICALS
公开号:WO2018050656A2
公开(公告)日:2018-03-22
The present disclosure relates to a class of mammalian heat shock factor (HSF) inhibitors, to pharmaceutical compositions comprising these inhibitors as well as to methods for using the inhibitors. The inhibitors inhibit stress-induced expression from heat shock gene promoters. Furthermore, the inhibitors are cytotoxic to a variety of human cancer cells types.
Production of surface-active agents with pronounced pharmacological activity
作者:V. I. Kabachnyi、V. P. Chernykh、G. I. Kabachnyi、E. M. Sopel'nik